Dataset of total, oligomeric alpha-synuclein and hemoglobin levels in plasma in Parkinson׳s disease

A Emelyanov; P Andoskin; S Pchelina

doi:10.1016/j.dib.2016.11.089

Dataset of total, oligomeric alpha-synuclein and hemoglobin levels in plasma in Parkinson׳s disease

Data Brief. 2016 Nov 28:10:182-185. doi: 10.1016/j.dib.2016.11.089. eCollection 2017 Feb.

Authors

A Emelyanov¹, P Andoskin², S Pchelina³

Affiliations

¹ Petersburg Nuclear Physics Institute, St. Petersburg, Russia; Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia; St. Petersburg Academic University - Nanothecnology Research and Education Centre, RAS, St. Petersburg, Russia.
² Petersburg Nuclear Physics Institute, St. Petersburg, Russia.
³ Petersburg Nuclear Physics Institute, St. Petersburg, Russia; Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia; St. Petersburg Academic University - Nanothecnology Research and Education Centre, RAS, St. Petersburg, Russia; Institute of Experimental Medicine, St. Petersburg, Russia.

Abstract

This data article presents a dataset of total, oligomeric alpha-synuclein and hemoglobin levels in plasma of drug-naïve PD patients and controls. This is the first attempt to assess the effect of hemolysis rate on oligomeric alpha-synuclein levels in peripheral plasma. The data are associated with the research article "Oligomeric alpha-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson׳s disease" (Pchelina et al., 2016) [1].